TrialClinical and translational science2022

A phase I study comparing the pharmacokinetics of the biosimilar (RD12014) with liraglutide (Victoza) in healthy Chinese male subjects.

Ruirui Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.